Chung Yoon in Suwanee, Georgia

Medical School: Medical College Of Georgia School Of Medicine
Graduation Year: 2009
The Primary Medical Specialty for Chung Yoon is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 16
PAC (PECOS ID)#: 0941466072
NPI #: 1235368630
NPI Created On: 07/07/2009
NPI Last Updated Listed as: 02/26/2021
Primary Taxonomy Code: 207R00000X
License Number:
Q9268
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Community Health Choice
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Routine ekg using at least 12 leads including interpretation and report
4. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
7. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
8. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
9. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
10. Follow-up or limited ultrasound examination of heart
11. New patient office or other outpatient visit, typically 45 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Initial hospital inpatient care, typically 70 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Technetium tc-99m tetrofosmin, diagnostic, per study dose
17. Injection, regadenoson, 0.1 mg